BCLS II Investco, LP 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 7:19 pm Purchase | 2025-11-05 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 11,422,504 9.990% | 703,394 (+6.56%) | Filing |
| 2024-12-17 5:35 pm Purchase | 2024-12-13 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 10,719,110 13.000% | 5,342,754 (+99.38%) | Filing |
| 2024-03-01 4:30 pm Unchanged | 2024-02-28 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 5,376,356 6.000% | 0 (Unchanged) | Filing |
| 2023-06-13 5:04 pm Purchase | 2023-06-09 | 13D | NewAmsterdam Pharma Company N.V. NAMS | BCLS II Investco, LP | 5,376,356 6.600% | 5,376,356 (New Position) | Filing |